Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development of cancer. The use of celecoxib may be an effective way to prevent the further
development of precancerous lesions in the mouth.
PURPOSE: Randomized phase II trial to compare the effectiveness of different regimens of
celecoxib in treating patients who have precancerous lesions in the mouth.